France· FR:64781800
CYSTAGON 150 mg, gélule
A medicinal product containing bitartrate de mercaptamine, registered in France by RECORDATI RARE DISEASES.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BITARTRATE DE MERCAPTAMINE
- Manufacturer
- RECORDATI RARE DISEASES
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400956097340flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bitartrate de mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandCYSTAGON 150 mg hard capsulesRecordati Rare Diseases
- CzechiaCYSTAGONRecordati Rare Diseases, Puteaux
- FinlandCystagonRecordati Rare Diseases
- United KingdomCystagon 150mg capsulesRecordati Rare Diseases UK Ltd
- IcelandCystagonRecordati Rare Diseases*
- NorwayCystagonRecordati Rare Diseases
- PolandCystagonRecordati Rare Diseases
- SwedenCystagon 150 mg Kapsel, hårdRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd6b7735-cb41-4775-8b6b-7544a3f8e093 GET /v1/drugs/cd6b7735-cb41-4775-8b6b-7544a3f8e093?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64781800",
"date_amm": "1997-06-23",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/97/039",
"substance": "BITARTRATE DE MERCAPTAMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bitartrate de mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.